Hematologic Neoplasms
📧 Sign up to get email alerts when something new happens for Hematologic Neoplasms.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-16EMA Authorised: Zemcelpro (allogeneic umbilical cord-derived CD34- cells, non-expanded;dorocubicel) — Cordex Biologics International Limited
EMA has authorised Zemcelpro (allogeneic umbilical cord-derived CD34- cells, non-expanded; dorocubicel) for hematologic neoplasms and hemato…
-
EMA approval · 2026-02-18EMA Authorised: Zemcelpro (allogeneic umbilical cord-derived CD34- cells, non-expanded;dorocubicel) — Cordex Biologics International Limited
EMA authorized Zemcelpro, an allogeneic cord-derived CD34- cell therapy (dorocubicel), for hematologic neoplasms and hematopoietic stem cell…